SCHEMBL30299607

SCHEMBL30299607

COc1cc(Nc2nc(-c3ccc4cn[nH]c4c3)cn3ncnc23)ccc1N1CCN(C)CC1

nearest known ligand 0.64

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SYK P43405 16/20 0.64
PDGFRB P09619 3/20 0.60
PDGFRA P16234 3/20 0.60
JAK2 O60674 1/20 0.45
NTRK1 P04629 1/20 0.45
ROS1 P08922 1/20 0.45
CSNK2A2 P19784 1/20 0.45
FLT3 P36888 1/20 0.45
CSNK2B P67870 1/20 0.45
CSNK2A1 P68400 1/20 0.45
BTK Q06187 1/20 0.45
PTK6 Q13882 1/20 0.45
CSNK2A3 Q8NEV1 1/20 0.45
STK33 Q9BYT3 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25298414 1.00 SYK (0.64) SYKPDGFRBPDGFRAJAK2NTRK1
SCHEMBL25249369 0.92 SYK (0.62) SYKPDGFRBPDGFRAJAK2NTRK1
SCHEMBL30299504 0.92 SYK (0.62) SYKPDGFRBPDGFRAJAK2NTRK1
SCHEMBL30299483 0.92 SYK (0.60) SYKPDGFRBPDGFRAJAK2NTRK1
SCHEMBL25255038 0.92 SYK (0.61) SYKPDGFRBPDGFRAJAK2NTRK1
SCHEMBL30299512 0.92 SYK (0.61) SYKPDGFRBPDGFRAJAK2NTRK1
SCHEMBL25247675 0.92 SYK (0.60) SYKPDGFRBPDGFRAJAK2NTRK1
SCHEMBL25252999 0.92 SYK (0.61) SYKPDGFRBPDGFRAJAK2NTRK1
SCHEMBL25245973 0.92 SYK (0.61) SYKPDGFRBPDGFRAJAK2NTRK1
SCHEMBL30299492 0.92 SYK (0.61) SYKPDGFRBPDGFRAJAK2NTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4157848-A1 COMPOUNDS AND THEIR USES AS SPLEEN TYROSINE KINASE INHIBITORS Nanjing Ruijie Pharma Co., Ltd. (CN) 2023-04-05 EP claimed
CN-115916782-A Compounds and their use as spleen tyrosine kinase inhibitors 南京瑞捷医药科技有限公司 2023-04-04 CN claimed
CN-115916782-B Compounds and their use as inhibitors of spleen tyrosine kinase 南京瑞捷医药科技有限公司 2024-08-13 CN disclosed
EP-4157848-A1 COMPOUNDS AND THEIR USES AS SPLEEN TYROSINE KINASE INHIBITORS Nanjing Ruijie Pharma Co., Ltd. (CN) 2023-04-05 EP disclosed
CN-115916782-A Compounds and their use as spleen tyrosine kinase inhibitors 南京瑞捷医药科技有限公司 2023-04-04 CN disclosed